Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the incidence of urinary and rectal acute side
effects of a pelvic and prostatic intensity-modulated arctherapy with simultaneous integrated
boost (SIB-IMRT)combined with long-term androgen deprivation for patients with high risk
localized prostate cancer